How is the treatment landscape changing for Hodgkin lymphoma? Tune in for news on novel immunotherapies, minimizing toxicities and side effect management strategies from Dr. John Sweetenham.
Published:
When can young adults with Hodgkin lymphoma return to work or school after treatment? Watch as Dr. Joshua Brody and Dr. Andrew Evens discuss the duration of therapy, side effects and recovery.
Published:
What does a survivorship care plan look like for Hodgkin lymphoma patients? Watch as Dr. Joshua Brody and Dr. Andrew Evens share long-term considerations for survivors, post-treatment risk factors and more.
Published:
Is CAR T-cell therapy on the horizon for patients with solid tumor cancers? Watch as Dr. David Maloney discusses advances in CAR-T research, current clinical studies, treatment efficacy and more.
Published:
How does Hodgkin lymphoma treatment affect fertility? Tune in as Dr. Andrew Evens and Dr. Joshua Brody offer expert perspectives on first- and second-line treatment approaches and the effects on fertility.
Published:
Is it important for Hodgkin lymphoma patients to undergo genetic testing at diagnosis? Watch as Dr. Joshua Brody and Dr. Andrew Evens discuss genomic changes that may occur and how they change the course of care.
Published:
What factors increase a person’s risk of cancer? Watch now to hear experts Dr. Joshua Brody and Dr. Andrew Evens discuss causes linked with the development of Hodgkin lymphoma.
Published:
How are novel agents being used in Hodgkin lymphoma care? Tune in to hear experts Dr. Andrew Evens and Dr. Joshua Brody discuss the use of targeted treatments and new frontline therapies.
Published:
Do disease characteristics differ among younger and older Hodgkin lymphoma patient populations? Watch as Dr. Joshua Brody and Dr. Andrew Evens discuss patient demographics for Hodgkin lymphoma.
Published:
